Open Market Insiders Trades
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- P - Open market or private purchase of non-derivative or derivative security
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
SMTC
|
Paul V Walsh Jr
Director |
SELL
Open market or private sale
|
Direct | 500 Reduced 1.94% |
$39,125
$78.25 p/Share
|
Jan 21
2026 |
|
IPGP
|
Angelo P Lopresti
SVP, Secretary & Gen Counsel |
SELL
Open market or private sale
|
Direct | 1,500 Reduced 2.5% |
$127,500
$85.0 p/Share
|
Jan 21
2026 |
|
EWTX
|
Badreddin Edris |
SELL
Open market or private sale
|
Direct | 115,471 Reduced 85.35% |
$3,399,466
$29.44 p/Share
|
Jan 21
2026 |
|
CCB
|
Eric M Sprink
CEO |
SELL
Open market or private sale
|
Direct | 8,402 Reduced 4.9% |
$960,096
$114.27 p/Share
|
Jan 21
2026 |
|
DRVN
|
Scott L. O'Melia
Chief Legal Officer |
SELL
Open market or private sale
|
Direct | 46,875 Reduced 12.54% |
$750,000
$16.0 p/Share
|
Jan 21
2026 |
|
MAX
|
Steven Yi
Director |
SELL
Open market or private sale
|
Direct | 8,000 Reduced 0.29% |
$88,160
$11.02 p/Share
|
Jan 21
2026 |
|
LIND
|
Sven Olof Lindblad |
SELL
Open market or private sale
|
Direct | 75,314 Reduced 0.64% |
$1,207,283
$16.03 p/Share
|
Jan 21
2026 |
|
MAX
|
Eugene Nonko
Director |
SELL
Open market or private sale
|
Direct | 5,400 Reduced 0.55% |
$59,508
$11.02 p/Share
|
Jan 21
2026 |
|
MAX
|
Eugene Nonko
Director |
SELL
Open market or private sale
|
Indirect | 6,700 Reduced 0.0% |
$73,834
$11.02 p/Share
|
Jan 21
2026 |
|
PLMR
|
Mac Armstrong
CEO and Chairman |
SELL
Open market or private sale
|
Indirect | 5,000 Reduced 0.0% |
$645,699
$129.14 p/Share
|
Jan 21
2026 |
|
BHE
|
Jeff Benck
CEO |
SELL
Open market or private sale
|
Direct | 14,900 Reduced 3.4% |
$748,576
$50.24 p/Share
|
Jan 21
2026 |
|
GH
|
Terilyn J. Monroe
Chief People Officer |
SELL
Open market or private sale
|
Direct | 8,571 Reduced 28.99% |
$975,722
$113.84 p/Share
|
Jan 21
2026 |
|
CSAI
|
Sheldon Richard Bentley
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 25,000 Reduced 14.29% |
$20,500
$0.82 p/Share
|
Jan 21
2026 |
|
AEO
|
Jay L Schottenstein
Exec Chairman & CEO |
SELL
Open market or private sale
|
Indirect | 527,343 Reduced 0.0% |
$13,621,269
$25.83 p/Share
|
Jan 21
2026 |
|
REPX
|
Bluescape Riley Exploration Holdings LLC |
SELL
Open market or private sale
|
Direct | 122,795 Reduced 3.02% |
$3,406,333
$27.74 p/Share
|
Jan 21
2026 |
|
MCB
|
Nick Rosenberg
Executive Vice President |
SELL
Open market or private sale
|
Direct | 1,250 Reduced 4.61% |
$112,762
$90.21 p/Share
|
Jan 21
2026 |
|
RBA
|
James Francis Kessler
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 20,742 Reduced 16.17% |
$2,385,330
$115.0 p/Share
|
Jan 21
2026 |
|
DTIL
|
J. Jefferson Smith
Chief Research Officer |
SELL
Open market or private sale
|
Direct | 10,200 Reduced 8.47% |
$41,106
$4.03 p/Share
|
Jan 21
2026 |
|
DTIL
|
John Alexander Kelly
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 15,213 Reduced 12.5% |
$61,308
$4.03 p/Share
|
Jan 21
2026 |
|
DTIL
|
Dario Scimeca
General Counsel and Secretary |
SELL
Open market or private sale
|
Direct | 8,854 Reduced 16.53% |
$35,681
$4.03 p/Share
|
Jan 21
2026 |
|
EVCM
|
Eric Richard Remer
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 6,776 Reduced 0.25% |
$82,802
$12.22 p/Share
|
Jan 21
2026 |
|
PAHC
|
Jack Bendheim
President and CEO |
SELL
Open market or private sale
|
Indirect | 14,687 Reduced 0.0% |
$612,154
$41.68 p/Share
|
Jan 21
2026 |
|
AMAL
|
Sam D. Brown
SEVP, Chief Banking Officer |
SELL
Open market or private sale
|
Direct | 5,151 Reduced 8.82% |
$182,860
$35.5 p/Share
|
Jan 21
2026 |
|
GCT
|
Lei Wu
Chief Executive Officer |
SELL
Open market or private sale
|
Indirect | 210 Reduced 0.0% |
$8,454
$40.26 p/Share
|
Jan 21
2026 |
|
ALMU
|
Mark N. Tompkins
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 45,000 Reduced 2.26% |
$894,600
$19.88 p/Share
|
Jan 21
2026 |
|
DSP
|
Christopher Vanderhook
Chief Operating Officer |
SELL
Open market or private sale
|
Indirect | 4,926 Reduced 0.0% |
$60,294
$12.24 p/Share
|
Jan 21
2026 |
|
DSP
|
Timothy Vanderhook
CEO and Chairman |
SELL
Open market or private sale
|
Indirect | 4,926 Reduced 0.0% |
$60,294
$12.24 p/Share
|
Jan 21
2026 |
|
DSP
|
Four Brothers 2 LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 14,778 Reduced 65.68% |
$180,882
$12.24 p/Share
|
Jan 21
2026 |
|
TINV-WT
|
Fu Bin Lu James |
SELL
Open market or private sale
|
Indirect | 200,000 Reduced 0.0% |
$2,398,000
$11.99 p/Share
|
Jan 21
2026 |
|
PL
|
Ashley F. Johnson
President & CFO |
SELL
Open market or private sale
|
Direct | 150,731 Reduced 7.15% |
$4,072,751
$27.02 p/Share
|
Jan 21
2026 |
|
NTRA
|
John Fesko
PRESIDENT, CHIEF BUS. OFFICER |
SELL
Open market or private sale
|
Direct | 339 Reduced 0.19% |
$79,665
$235.0 p/Share
|
Jan 21
2026 |
|
NTRA
|
Solomon Moshkevich
PRESIDENT, CLINICALDIAGNOSTICS |
SELL
Open market or private sale
|
Direct | 293 Reduced 0.2% |
$68,855
$235.0 p/Share
|
Jan 21
2026 |
|
NTRA
|
Daniel Rabinowitz
SEC. AND CHIEF LEGAL OFFICER |
SELL
Open market or private sale
|
Direct | 438 Reduced 0.19% |
$102,930
$235.0 p/Share
|
Jan 21
2026 |
|
NTRA
|
Jonathan Sheena |
SELL
Open market or private sale
|
Direct | 3,163 Reduced 1.18% |
$743,241
$234.98 p/Share
|
Jan 21
2026 |
|
TKO
|
Seth D Krauss |
SELL
Open market or private sale
|
Direct | 14,016 Reduced 86.06% |
$2,817,496
$201.02 p/Share
|
Jan 21
2026 |
|
AZZ
|
Tara D Mackey
Chief Legal Officer |
SELL
Open market or private sale
|
Direct | 2,790 Reduced 9.93% |
$353,325
$126.64 p/Share
|
Jan 21
2026 |
|
SFIX
|
Casey O'Connor
Chief Legal Officer |
SELL
Open market or private sale
|
Direct | 13,852 Reduced 2.49% |
$73,969
$5.34 p/Share
|
Jan 21
2026 |
|
CRMD
|
Janet Dillione
Director |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 20.63% |
$68,800
$6.88 p/Share
|
Jan 21
2026 |
|
NTRA
|
Michael Burkes Brophy
CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct | 37,175 Reduced 36.7% |
$8,878,505
$238.83 p/Share
|
Jan 21
2026 |
|
NTRA
|
Steven Leonard Chapman
CEO AND PRESIDENT |
SELL
Open market or private sale
|
Direct | 1,590 Reduced 0.72% |
$373,650
$235.0 p/Share
|
Jan 21
2026 |
|
UAA
|
V Prem Et Al Watsa
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 5,000,000 Added 0.0% |
$29,450,000
$5.89 p/Share
|
Jan 21
2026 |
|
WRB
|
Mitsui Sumitomo Insurance CO LTD |
BUY
Open market or private purchase
|
Direct | 320,000 Added 0.59% |
$21,526,400
$67.27 p/Share
|
Jan 21
2026 |
|
AGE
|
Randall Moreadith
Chief Scientific Officer |
SELL
Open market or private sale
|
Direct | 2,000 Reduced 100.0% |
$6,000
$3.0 p/Share
|
Jan 21
2026 |
|
OM
|
John L. Brottem
General Counsel |
SELL
Open market or private sale
|
Direct | 1,180 Reduced 3.19% |
$5,911
$5.01 p/Share
|
Jan 21
2026 |
|
OM
|
Marc Nash
EVP Operations R&D & Service |
SELL
Open market or private sale
|
Direct | 980 Reduced 2.29% |
$4,880
$4.98 p/Share
|
Jan 21
2026 |
|
CABA
|
Steve Gavel
Chief Commercial Officer |
BUY
Open market or private purchase
|
Direct | 22,170 Added 50.0% |
$50,325
$2.27 p/Share
|
Jan 21
2026 |
|
CABA
|
Shawn Tomasello |
BUY
Open market or private purchase
|
Indirect | 22,725 Added 0.0% |
$50,222
$2.21 p/Share
|
Jan 21
2026 |
|
CABA
|
Gwendolyn Binder
President, Science & Tech. |
BUY
Open market or private purchase
|
Direct | 11,312 Added 26.54% |
$24,773
$2.19 p/Share
|
Jan 21
2026 |
|
CABA
|
David J. Chang
Chief Medical Officer |
BUY
Open market or private purchase
|
Direct | 8,800 Added 50.0% |
$19,887
$2.26 p/Share
|
Jan 21
2026 |
|
CABA
|
Michael Gerard
General Counsel |
BUY
Open market or private purchase
|
Direct | 6,600 Added 50.0% |
$14,982
$2.27 p/Share
|
Jan 21
2026 |